GlassScriptPhysician profile
Michael S Truitt
NPI 1356497937
$50,219.56
in general payments reported to CMS, 2019-2025
25 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $14K · 2021: $16K · 2022: $1,767 · 2023: $7,496 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,292 · Travel and Lodging: $965 · Food and Beverage: $450 · Consulting Fee: $23.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,292.00 |
| Travel and Lodging | $965.15 |
| Food and Beverage | $450.15 |
| Consulting Fee | $23.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $48,422.90 | 2019-2023 | On-Q, On-Q* Pump and Accessories |
| Biom'Up Sa | $330.54 | 2019 | |
| Csl Behring | $204.61 | 2019-2021 | |
| Boston Scientific Corporation | $154.02 | 2023-2025 | Spyglass Discover, Spyglass |
| Allergan, INC. | $142.28 | 2020-2022 | |
| Kci USA, INC. | $131.28 | 2020-2022 | |
| Baxter Healthcare | $108.82 | 2021 | |
| Stryker Corporation | $89.26 | 2021-2022 | |
| Pfizer INC. | $79.00 | 2019-2022 | |
| Intuitive Surgical, INC. | $77.91 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $66.27 | 2022-2023 | |
| Smith+Nephew, INC. | $63.93 | 2022-2025 | Versajet, Pico 14, Renasys Touch |
| Mallinckrodt Enterprises LLC | $54.10 | 2019 | |
| Ethicon US, LLC | $51.13 | 2021-2022 | |
| Tela Bio, INC. | $49.43 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $36.23 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Pacira Pharmaceuticals Incorporated | $26.03 | 2020-2021 | |
| Abbvie INC. | $24.52 | 2023 | Alloderm |
| Sanara Medtech INC. | $18.96 | 2022 | |
| Merck Sharp & Dohme LLC | $17.97 | 2021 | |
| Cook Medical LLC | $17.75 | 2020 | |
| Teleflex LLC | $15.83 | 2019 | |
| Mallinckrodt Hospital Products INC. | $14.74 | 2020 | |
| Kls-Martin L.P. | $12.75 | 2020 | |
| Bolder Surgical LLC | $9.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Truitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.